Boston Scientific Corporation (BSX)
BSX Price and Sentiment
BSX Latest news
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript
3 hours agoBoston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript
Boston Scientific (BSX) Q3 Earnings Top Estimates, Margins Up
3 hours agoBarring CRM, Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in Q3.
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
6 hours agoBoston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales increased 10.3% Y/Y on a reported basis and 10.6% on an organic basis, lower than the Company's guidance of 12% - 14%.
Boston Scientific (BSX) Q3 Earnings Beat Estimates
6 hours agoBoston Scientific (BSX) delivered earnings and revenue surprises of 2.50% and -1.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Boston Scientific Q3 Earnings
8 hours agoBoston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
Boston Scientific stock gains after profit tops expectations, while sales came up a bit short
8 hours agoShares of Boston Scientific Corp. BSX, -0.38% rose 0.4% in premarket trading Wednesday, after the medical device company reported third-quarter profit that topped expectations, but sales that came up a bit shy, while nudging up its earnings outlook and cutting its sales growth view. The company swung to net income of $405 million, or 28 cents a share, from a loss of $169 million, or 12 cents a share, in the year-ago period.
Boston Scientific Announces Results For Third Quarter 2021
9 hours agoMARLBOROUGH, Mass., Oct. 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported basis, 9.7 percent on an operational1 basis and 10.6 percent on an organic2 basis, all compared to the prior year period.
Medical Products Stock Q3 Earnings on Oct 27: TMO, EW & More
2021-10-26 11:50With the pandemic raging on, testing, vaccine and therapeutic makers witness huge market adoption of their COVID-related support products in Q3.
What To Expect From Boston Scientific Stock In Q3?
2021-10-25 06:00Boston Scientific is scheduled to report its Q3 2021 results on Wednesday, Oct 27. We expect the company to report revenues and earnings in-line with the consensus estimates, driven by a rebound in volume of procedures performed.
Boston Scientific (BSX) Product Launches to Drive Q3 Earnings
2021-10-21 17:27Within Urology/ Pelvic Health, Boston Scientific (BSX) is expected to have registered strong sales growth in Stone, Prostate Health and Pelvic Health franchises.